Patents by Inventor Perry S. Eisman

Perry S. Eisman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of pagoclone for the treatment of social anxiety disorder
    Patent number: 7553847
    Abstract: The present invention provides methods for treating social anxiety disorder, comprising administering 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone or 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-5-hydroxy-2-oxohexyl) -1-isoindolinone or pharmaceutically acceptable salt, or optical isomer therof, and optionally comprising administering another compound for the treatment of social anxiety disorder that is a GABA agonist.
    Type: Grant
    Filed: February 13, 2006
    Date of Patent: June 30, 2009
    Assignee: Indevus Pharmaceuticals, Inc.
    Inventors: Cathryn M. Clary, Jeroen Van Beek, Perry S. Eisman, Sean Donevan, Atul Pande, Richard Kavoussi, Lyou-Fu Ma
  • Methods of treating obsessive-compulsive disorder
    Patent number: 7026332
    Abstract: Methods of treating obsessive-compulsive disorder comprising administering 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone are disclosed.
    Type: Grant
    Filed: April 25, 2002
    Date of Patent: April 11, 2006
    Assignee: Indevus Pharmaceuticals, Inc.
    Inventors: Cathryn M. Clary, Jeroen Van Beek, Perry S. Eisman, Sean Donevan, Atul Pande, Richard Kavoussi, Lyou-Fu Ma
  • Methods, kits and compositions for using pyrrole derivatives
    Publication number: 20030022915
    Abstract: The present invention provides methods and kits for treating obsessive-compulsive disorder, acute stress disorder, post traumatic stress disorder, social anxiety disorder, somatization disorder, specific social phobia, premenstrual dysphoric disorder, anxiety associated with a medical condition, adjustment disorder with anxious mood, dysthymia, specific phobia or fibromyalgia using a compound of Formula I or a pharmaceutically acceptable salt, optical isomer or prodrug thereof 1
    Type: Application
    Filed: April 25, 2002
    Publication date: January 30, 2003
    Inventors: Cathryn M. Clary, Jeroen Van Beek, Perry S. Eisman, Sean Donevan, Atul Pande, Richard Kavoussi, Lyou-Fu Ma